GlobalData on MSN18h
Royalty Pharma pays $250m for rights to Biogen’s lupus drug
Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...
NYC mayor preps executive order allowing ICE agents into Rikers Island after meeting border czar
Border czar Tom Homan met with New York City Mayor Eric Adams on Thursday in a sign of how the Trump administration has its ...
Nicotine Gums And Mints Market To Surpass USD 2.69 Billion By 2034 Amid Rising Demand For Smoking Cessation Aids
Nicotine Gums and Mints market to Witness Substantial Growth Amid Rising Demand for Smoking Cessation Products Ankush Nikam Future Market Insights, Inc. + +91 90966 84197 email us here Visit us on ...
Primary Biliary Cholangitis Clinical Trial Pipeline 20+ Companies Pioneering The Future Of Treatment
Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...
U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Prediction: Scottish Mortgage shares will beat the FTSE 100 index in 2025
Scottish Mortgage shares have started 2025 well, delivering a double-digit gain already. Edward Sheldon's optimistic this ...
Business Today21h
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) Share Price
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...
Business Standard16h
Glaxosmithkline Pharmaceuticals Share Price
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc. a global biopharma company to unite science technology and talent to get ahead of disease together. The Company is ...